28
Oct
2025

Hangzhou Jiuyuan Gene Engineering Co.,Lt

Exhibitor at CPHI Frankfurt 2025 stand 3.0L56, Finished Dosage Formulations
About Us

We are a leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Liraglutide(recombinant)，Enoxaparin sodium, Fulvestrant, Interleukin-11, Palonosetron Hydrochloride, rhBMP-2 , Fosaprepitant dimeglumine. Our product pipeline include: Semaglutide (recombinant), Semaglutide intermediate (Totally 29 amino acids), Recombinant Hyaluronidase, Pegfilgrastim, Dulaglutide,  Avatrombopag maleate, Daratumumab, Romosozumab, amylin analog, CD47-SIPR.


Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.0L56, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Semaglutide

    Product Semaglutide

    Diabetes and Obesity
  • Filgrastim

    Product Filgrastim

    Filgrastim, Neupogen, G-CSF, Indicated to neutropenia, Formulated bulk liquid, l  Injection (ampoule/PFS/vial) 75µg/unit, 150µg/unit, 300µg/unit, 450µg/unit

  • Fosaprepitant dimeglumine

    Product Fosaprepitant dimeglumine

    cancerbrhrbrEmend, CAS number: 265121-04-8
  • Dulaglutide

    Product Dulaglutide

    diabetes (recombinant route), API
  • Fulvestrant

    Product Fulvestrant

    an anti-cancer drug, Bulk and injection (PFS): 250mg in 5ml

  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API) , Injection (ampoule): 0.25mg/5ml


  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapy， Active pharmaceutical ingredient (API)，Injection (ampoule): 0.25mg/5ml

  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapybrhrbrPalonosetron, Aloxi
  • Pegfilgrastim

    Product Pegfilgrastim

    long lasting filgrastim, pegylated filgrastim, neulasta
  • PegFilgrastim

    Product PegFilgrastim

    a long lasting rhG-CSF, Bulk and injection (PFS): 6mg in 0.6ml
  • Ranibizumab

    Product Ranibizumab

    Wet Macular Degeneration, API 
  • Recombinant Human Bone Morphogenetic Protein-2

    Product Recombinant Human Bone Morphogenetic Protein-2

    rhBMP-2,  a new bone repair material，registered as an implanted medical device,  Active pharmaceutical ingredient (API), l  Tablet (vial): 1mg/vial


  • Recombinant Human Bone Morphogenetic Protein-2

    Product Recombinant Human Bone Morphogenetic Protein-2

    rhBMP-2， a new bone repair material，registered as an implanted medical device， Active pharmaceutical ingredient (API)，Tablet (vial): 1mg/vial

  • Recombinant Human Interleukin-11

    Product Recombinant Human Interleukin-11

    rhIL-11,  Oprelvekin, a drug to increase platelet count, l  Lyophilized powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial


  • Recombinant Human Interleukin-11

    Product Recombinant Human Interleukin-11

    rhIL-11 (Oprelvekin)， a drug to increase platelet count，Lyophilized powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial

  • rhBMP-2

    Product rhBMP-2

    a new bone repairing materialbrhrbrrecombinant human Bone Morphogenetic Protein-2, bone reparing, BMP-2, BMP
  • semaglutide

    Product semaglutide

    diabetes (recombinant route),  API